Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » OncoCyte Enters Deal to Offer $7.6M in Stock

OncoCyte Enters Deal to Offer $7.6M in Stock

Jan 03, 2020
|
staff reporter

NEW YORK – Diagnostics firm OncoCyte said on Thursday that it has entered into definitive agreements with Pura Vida Investments, a healthcare focused registered investment advisor, and one other unnamed institutional investor, to purchase approximately $7.6 million of the company's common shares in a registered offering. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Test Evaluations

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

Justification for Stricter Standards Sought

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

Concerns Over Comment

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

PLOS Papers on Tremor Condition, Medical Plant Populations, Brewing Yeast Transcriptomics

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.

What's Popular?

In Business News

  1. Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

  2. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  3. Ionpath Expanding Sales Force, Investing in Informatics Tools Development

    Premium

  4. Zymo Research Gets CE-IVD Mark for Sample Collection Devices

  5. Ceres Nanosciences Nabs $243K SBIR Grant to Adapt RNA Capture Tech for Portable Sequencing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.